Must & More Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 07-07-2024
- Paid Up Capital ₹ 0.17 M
as on 07-07-2024
- Company Age 34 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.66 M
as on 07-07-2024
- Satisfied Charges ₹ 88.19 M
as on 07-07-2024
- Revenue -64.76%
(FY 2023)
- Profit -144.31%
(FY 2023)
- Ebitda -106.92%
(FY 2023)
- Net Worth -104.83%
(FY 2023)
- Total Assets -30.98%
(FY 2023)
About Must & More Diagnostics
The Corporate was formerly known as Bimal Hospital Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.17 M.
The company currently has active open charges totaling ₹0.66 M. The company has closed loans amounting to ₹8.82 Cr, as per Ministry of Corporate Affairs (MCA) records.
Daksh Gupta, Amit Gupta, and Praveen Gupta serve as directors at the Company.
- CIN/LLPIN
U74899DL1990PTC040560
- Company No.
040560
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jun 1990
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Must & More Diagnostics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Praveen Gupta  | Director | 01-Apr-1997 | Current |
| Daksh Gupta | Director | 01-Jun-2018 | Current |
| Amit Gupta | Director | 29-Apr-2017 | Current |
Financial Performance and Corporate Structure Insights of Must & More Diagnostics.
Must & More Diagnostics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 64.76% decrease. The company also saw a substantial fall in profitability, with a 144.31% decrease in profit. The company's net worth observed a substantial decline by a decrease of 104.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Must & More Diagnostics?
In 2023, Must & More Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Must & More Health Care Private Limited
Active 12 years 6 monthsDaksh Gupta and Amit Gupta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Bank Limited Creation Date: 26 May 2008 | ₹0.66 M | Open |
Others Creation Date: 29 Jul 2019 | ₹7.50 M | Satisfied |
Yes Bank Limited Creation Date: 06 Apr 2015 | ₹3.67 Cr | Satisfied |
How Many Employees Work at Must & More Diagnostics?
Unlock and access historical data on people associated with Must & More Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Must & More Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Must & More Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
